Rel-(R)-N-((R)-(3,5-di-tert-butyl-4-methoxyphenyl)(5-(diphenylphosphaneyl)-9,9-dimethyl-9H-xanthen-4-yl)methyl)-2-methylpropane-2-sulfinamide

Catalog No. :
ACOHPQ841
CAS No. :
2832620-06-9
Molecular Formula :
C47H56NO3PS
Molecular Weight :
746.01

IUPAC Name:(R)-N-((R)-(3,5-di-tert-butyl-4-methoxyphenyl)(5-(diphenylphosphaneyl)-9,9-dimethyl-9H-xanthen-4-yl)methyl)-2-methylpropane-2-sulfinamide

Rel-(R)-N-((R)-(3,5-di-tert-butyl-4-methoxyphenyl)(5-(diphenylphosphaneyl)-9,9-dimethyl-9H-xanthen-4-yl)methyl)-2-methylpropane-2-sulfinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-(R)-N-((R)-(3,5-di-tert-butyl-4-methoxyphenyl)(5-(diphenylphosphaneyl)-9,9-dimethyl-9H-xanthen-4-yl)methyl)-2-methylpropane-2-sulfinamide
IUPAC Name(R)-N-((R)-(3,5-di-tert-butyl-4-methoxyphenyl)(5-(diphenylphosphaneyl)-9,9-dimethyl-9H-xanthen-4-yl)methyl)-2-methylpropane-2-sulfinamide
Molecular FormulaC47H56NO3PS
Molecular Weight746.01
SMILESCC([S@](N[C@H](C1=CC(C(C)(C)C)=C(OC)C(C(C)(C)C)=C1)C2=CC=CC(C3(C)C)=C2OC4=C3C=CC=C4P(C5=CC=CC=C5)C6=CC=CC=C6)=O)(C)C
InChI KeyBCSWMDYGGCPTPC-UGQLXJPCSA-N
CAS No.2832620-06-9

Synthetic Route by SureRoute

1. ACOHPQ841 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEIHU089 route compound structure diagram
    ACEIHU089196929-78-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOHPQ841 route product structure diagram
    ACOHPQ8412832620-06-9
Inquiry

2. ACOHPQ841 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEIHU089 route compound structure diagram
    ACEIHU089196929-78-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOHPQ841 route product structure diagram
    ACOHPQ8412832620-06-9
Inquiry

Comments (0)